The relationship between serum hypoxia-inducible factor 1α and coronary artery calcification in asymptomatic type 2 diabetic patients

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Li, Gang ^a   Lu, Wei hua ^a   Ai, Rong ^b   Yang, Jian hong ^a   Chen, Fang ^a   Tang, Zhong zhi ^a  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Coronary artery calcification; Hypoxia inducible factor 1 ; Type 2 diabetes mellitus

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; COMPUTED TOMOGRAPHY SCANNER; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; DIABETIC PATIENT; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM PROSPECTIVE DIABETES STUDY RISK SCORE;

ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; VASCULAR CALCIFICATION;

EID: 84896699214     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-52     Document Type: Article

References (53)

1. Abedin M, Tintut Y, Demer LL. Vascular calcification mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004, 24(7):1161-1170. 10.1161/01.ATV.0000133194.94939.42, 15155384.
2. Kovacic JC, Fuster V. Vascular calcification, diabetes, and cardiovascular disease connecting the dots. J Am Coll Cardiol Img 2012, 5(4):367-369.
3. Shroff RC, Shanahan CM. The vascular biology of calcification. Semin Dial 2007, 20:103-109. 10.1111/j.1525-139X.2007.00255.x, 17374082.
4. Giachelli CM. The emerging role of phosphate in vascular calcification. Kidney Int 2009, 75:890-897. 10.1038/ki.2008.644, 2807740, 19145240.
5. Magne D, Julien M, Vinatier C, Merhi-Soussi F, Weiss P, Guicheux J. Cartilage formation in growth plate and arteries: from physiology to pathology. Bioessays 2005, 27:708-716. 10.1002/bies.20254, 15954094.
6. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006, 99:1044-1059. 10.1161/01.RES.0000249379.55535.21, 17095733.
7. Idelevich A, Rais Y, Monsonego-Ornan E. Bone Gla protein increases HIF-1α-dependent glucose metabolism and induces cartilage and vascular calcification. Arterioscler Thromb Vasc Biol 2011, 31:e55-e71. 10.1161/ATVBAHA.111.230904, 21757657.
8. Kapustin AN, Shanahan CM. Osteocalcin: a novel vascular metabolic and osteoinductive factor?. Arterioscler Thromb Vasc Biol 2011, 31:2169-2171. 10.1161/ATVBAHA.111.233601, 21918209.
9. Hou ZH, Lu B, Gao Y, Jiang SL, Wang Y, Li W, Budoff MJ. Prognostic value of coronary CT angiography and calcium score for major adverse cardiac events in outpatients. J Am Coll Cardiol Img 2012, 5:990-999.
10. O'Donnell CJ, Kavousi M, Smith AV, Kardia SLR, Feitosa MF, Hwang S-J, Sun YV, Province MA, Aspelund T, Dehghan A, Hoffmann U, Bielak LF, Zhang Q, Eiriksdottir G, van Duijn CM, Fox CS, de Andrade M, Kraja AT, Sigurdsson S, Elias-Smale SE, Murabito JM, Launer LJ, van der Lugt A, Kathiresan S, Krestin GP, Herrington DM, Howard TD, Liu Y, Post W, Mitchell BD, et al. Genome-Wide association study for coronary artery calcification with follow-up in myocardial infarction clinical perspective. Circulation 2011, 124(25):2855-2864. 10.1161/CIRCULATIONAHA.110.974899, 3397173, 22144573.
11. Graham G, Blaha MJ, Budoff MJ, Rivera JJ, Agatston A, Raggi P, Nasir K. Impact of coronary artery calcification on all-cause mortality in individuals with and without hypertension. Atherosclerosis 2012, 225(2):432-437. 10.1016/j.atherosclerosis.2012.08.014, 23078882.
12. Budoff MJ, Hokanson JE, Nasir K, Shaw LJ, Kinney GL, Chow D, DeMoss D, Nuguri V, Nabavi V, Ratakonda R, Berman DS, Raggi P. Progression of coronary artery calcium predicts all-cause mortality. J Am Coll Cardiol Img 2010, 3(12):1229-1236.
13. Agarwal S, Morgan T, Herrington DM, Xu JZ, Cox AJ, Freedman BI, Carr JJ, Bowden DW. Coronary calcium score and prediction of all-cause mortality in diabetes the diabetes heart study. Diabetes Care 2011, 34(5):1219-1224. 10.2337/dc11-0008, 3114476, 21398528.
14. Wong ND, Sciammarella MG, Polk D, Gallagher A, Miranda-Peats L, Whitcomb B, Hachamovitch R, Friedman JD, Hayes S, Berman DS. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol 2003, 41:1547-1553.
15. Olson JC, Edmundowicz D, Becker DJ, Kuller LH, Orchard TJ. Coronary calcium in adults with type 1 diabetes. Diabetes 2000, 49:1571-1578. 10.2337/diabetes.49.9.1571, 10969842.
16. Mileke CH, Shields JP, Broemeling LD. Coronary artery calcium, coronary artery disease, and diabetes. Diabetes Res Clin Practice 2001, 53:55-61.
17. Proudfoot D, Shanahan CM. Biology of calcification in vascular cells: intima versus media. Herz 2001, 26(4):245-251. 10.1007/PL00002027, 11479936.
18. Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004, 15(12):2959-2964. 10.1097/01.ASN.0000145894.57533.C4, 15579497.
19. Stevens RJ, Kothari V, Adler AI, Stratton IM, Holman RR, United Kingdom Prospective Diabetes Study (UKPDS) Group The UKPDS risk engine: a model for the risk of coronary heart disease in type 2 diabetes (UKPDS 56). Clin Sci 2001, 101:671-679. 10.1042/CS20000335, 11724655, United Kingdom Prospective Diabetes Study (UKPDS) Group.
20. Hong C, Bae KT, Pilgram TK. Coronary artery calcium: accuracy and reproducibility of measurements with multi-detector row CT-assessment of effects of different thresholds and quantification methods. Radiology 2003, 227:795-801. 10.1148/radiol.2273020369, 12728184.
21. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 2003, 228:826-833. 10.1148/radiol.2283021006, 12869688.
22. Shemesh J, Tenenbaum A, Fisman EZ, Koren-Morag N, Grossman E. Coronary calcium in patients with and without diabetes: first manifestation of acute or chronic coronary events is characterized by different calcification patterns. Cardiovasc Diabetol 2013, 12(1):161. 10.1186/1475-2840-12-161, 24188692.
23. Lau KK, Wong YK, Chan YH, Yiu KH, Teo KC, Li LS, Ho SL, Chan KH, Siu CW, Tse HF. Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with type 2 diabetes. Cardiovasc Diabetol 2012, 11:101. 10.1186/1475-2840-11-101, 3444371, 22900680.
24. van Eupen MG, Schram MT, Colhoun HM, Scheijen JL, Stehouwer CD, Schalkwijk CG. Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification. Cardiovasc Diabetol 2013, 17(12(1)):149.
25. Veerman KJ, Venegas-Pino DE, Shi Y, Khan MI, Gerstein HC, Werstuck GH. Hyperglycaemia is associated with impaired vasa vasorum neovascularization and accelerated atherosclerosis in apolipoprotein-E deficient mice. Atherosclerosis 2013, 227(2):250-258. 10.1016/j.atherosclerosis.2013.01.018, 23411040.
26. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011, 364:656-665. 10.1056/NEJMra0910283, 3930928, 21323543.
27. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012, 3:148.
28. Ke QD, Costa M. Hypoxia-inducible factor-1(HIF-1). Mol Pharmacol 2006, 70:1469-1480. 10.1124/mol.106.027029, 16887934.
29. Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001, 44:1973-1988. 10.1007/s001250100001, 11719828.
30. Catrina SB, Okamoto K, Pereira T, Brismar K, Poellinger L. Hyperglycemia regulates hypoxia-inducible factor-1α protein stability and function. Diabetes 2004, 53:3226-3232. 10.2337/diabetes.53.12.3226, 15561954.
31. Bento CF, Pereira P. Regulation of hypoxia-inducible factor 1 and the loss of the cellular response to hypoxia in diabetes. Diabetologia 2011, 54:1946-1956. 10.1007/s00125-011-2191-8, 21614571.
32. Jiang CT, Qu AJ, Matsubara T, Chanturiya T, Jou W, Gavrilova O, Shah YM, Gonzalez FJ. Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice. Diabetes 2011, 60:2484-2495. 10.2337/db11-0174, 3178277, 21873554.
33. Shin MK, Drager LF, Yao QL, Bevans-Fonti S, Yoo DY, Jun JC, Aja S, Bhanot S, Polotsky VY. Metabolic consequences of high-fat diet are attenuated by suppression of HIF-1α. PLoS One 2012, 7(10):e46562. 10.1371/journal.pone.0046562, 3462192, 23049707.
34. Yamada N, Horikawa Y, Oda N, Iizuka K, Shihara N, Kishi S, Takeda J. Genetic variation in the hypoxia-inducible factor-1α gene is associated with type 2 diabetes in Japanese. J Clin Endocrinol Metab 2005, 90:5841-5847. 10.1210/jc.2005-0991, 16046581.
35. Nagy G, Kovacs-Nagy R, Kereszturi E, Somogyi A, Szekely A, Nemeth N, Hosszufalusi N, Panczel P, Ronai Z, Sasvari-Szekely M. Association of hypoxia inducible factor-1 alpha gene polymorphism with both type 1 and type 2 diabetes in a Caucasian (Hungarian) sample. BMC Med Genet 2009, 10:79. 2736933, 19691832.
36. Liang J, Qian Y, Xu D, Yin Q, Pan HJ, Serum Tumor Markers Hypoxia-inducible factor-1α HIF-1α and vascular endothelial growth factor, in patients with non-small cell lung cancer before and after intervention. Asian Pac J Cancer Prev 2013, 14(6):3851-3854. 10.7314/APJCP.2013.14.6.3851, 23886195, Serum Tumor Markers.
37. Ece H, Cigdem E, Yuksel K, Ahmet D, Hakan E, Oktay TM. Use of oral antidiabetic drugs (Metformin and Pioglitazone) in diabetic patients with breast cancer: how does it effect on serum Hif-1 alpha and 8Ohdg levels?. Asian Pac J Cancer Prev 2012, 13(10):5143-5148. 10.7314/APJCP.2012.13.10.5143, 23244125.
38. Doherty TM, Fitzpatrick LA, Inoue D, Qiao JH, Fishbein MC, Detrano RC, Shah PK, Rajavashisth AB. Molecular, endocrine and genetic mechanisms of arterial calcification. Endocr Rev 2004, 25:629-672. 10.1210/er.2003-0015, 15294885.
39. Wu Y, Cao H, Yang Y, Zhou Y, Gu Y, Zhao X, Zhang Y, Zhao Z, Zhang L, Yin J. Effects of vascular endothelial cells on osteogenic differentiation of noncontact co-cultured periodontal ligament stem cells under hypoxia. J Periodontal Res 2013, 48(1):52-65. 10.1111/j.1600-0765.2012.01503.x, 22905750.
40. Sakakura Y, Shibui T, Irie K, Yajima T. Metabolic mode peculiar to Meckel's cartilage: immunohistochemical comparisons of hypoxia-inducible factor-1α and glucose transporters in developing endochondral bones in mice. Eur J Oral Sci 2008, 116(4):341-352. 10.1111/j.1600-0722.2008.00548.x, 18705802.
41. D'Ippolito G, Diabira S, Howard GA, Roos BA, Schiller PC. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI. Cells Bone 2006, 39(3):513-522.
42. Hartmann G, Tsch PM, Fischer R, Bidlingmaier C, Riepl R, Tschöp K, Hautmann H, Endres S, Toepfer M. High altitude increases circulating interleukin- 6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 2000, 12:246-252. 10.1006/cyto.1999.0533, 10704252.
43. Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, Semenza GL. Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2. Cancer Res 1999, 59(16):3915-3918.
44. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1β-mediated up-regulation of HIF-1α via an NFκB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 2003, 17(14):2115-2117.
45. Albina JE, Mastrofrancesco B, Vessella JA, Louis CA, Henry WL, Reichner JS. HIF-1 expression in healing wounds: HIF-1α induction in primary inflammatory cells by TNF-α. Am J Physiol Cell Physiol 2001, 281(6):c1971-c1977.
46. Wolf G, Schroeder R, Stahl RAK. Angiotensin II induces hypoxia-inducible factor-1α in PC 12 cells through a posttranscriptional mechanism: role of AT2 receptors. Am J Nephrol 2004, 24(4):415-421. 10.1159/000080086, 15308873.
47. Déry MAC, Michaud MD, Richard DE. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 2005, 37(3):535-540. 10.1016/j.biocel.2004.08.012, 15618010.
48. Wood IS, de Heredia FP, Wang B, Trayhurn P. Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc 2009, 68:370-377. 10.1017/S0029665109990206, 19698203.
49. Fleischmann E, Kurz A, Niedermayr M, Schebesta K, Kimberger O, Sessler DI, Kabon B, Prager G. Tissue oxygenation in obese and non-obese patients during laparoscopy. Obes Surg 2005, 15:813-819. 10.1381/0960892054222867, 1351376, 15978153.
50. Yin J, Zhanguo G, He Q, Zhou D, Guo Z, Ye J. Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue. Am J Physiol Endocrinol Metab 2009, 296:E333-E342. 2645021, 19066318.
51. Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, Wang ZV, Landskroner-Eiger S, Dineen S, Magalang UJ, Brekken RA, Scherer PE. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 2009, 29:4467-4483. 10.1128/MCB.00192-09, 2725728, 19546236.
52. Krishnan J, Danzer C, Simka T, Ukropec J, Walter KM, Kumpf S, Mirtschink P, Ukropcova B, Gasperikova D, Pedrazzini T, Krek W. Dietary obesity-associated Hif1alpha activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD + system. Genes Dev 2012, 26:259-270. 10.1101/gad.180406.111, 3278893, 22302938.
53. Pan CY, Yang WY, Jia WP, Weng JP, Tian H. Management of Chinese patients with type 2 diabetes, 1998-2006: the Diabcare-China surveys. Curr Med Res Opin 2009, 1(25):39-45.